1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 37
2.5 Porters Fiver Forces Analysis 41
3 Segmentation of Europe Market by System Component 45
3.1 Market Overview by System Component 45
3.2 Data Collection Tools 47
3.2.1 Digital Platforms 49
3.2.2 Mobile Apps 50
3.2.3 Desktop-based Software 51
3.2.4 Wearables 52
3.2.5 Biosensors 53
3.3 Data Integration Systems 54
4 Segmentation of Europe Market by Therapeutic Area 55
4.1 Market Overview by Therapeutic Area 55
4.2 Cardiovascular Diseases 57
4.3 Neurodegenerative Disorders 58
4.3.1 Parkinsons Disease 60
4.3.2 Multiple Sclerosis 61
4.3.3 Alzheimers Disease 62
4.4 Sleep and Movement Diseases 63
4.5 Psychiatric Disorders 64
4.6 Chronic Pain 65
4.7 Gastrointestinal Diseases 66
4.8 Diabetes 67
4.9 Respiratory Conditions 68
4.10 Other Diseases 69
5 Segmentation of Europe Market by Application 70
5.1 Market Overview by Application 70
5.2 Wellness 72
5.3 Disease Diagnosis 73
5.4 Personalised Medication 74
5.5 Drug Discovery and Development 75
6 Segmentation of Europe Market by Development Status 77
6.1 Market Overview by Development Status 77
6.2 Novel Digital Biomarkers 80
6.3 Original Digital Biomarkers 81
6.4 Approved Digital Biomarkers 82
7 Segmentation of Europe Market by End User 83
7.1 Market Overview by End User 83
7.2 Biopharmaceutical Companies & Labs 85
7.3 Healthcare Providers 86
7.4 Insurance Payers 87
8 European Market 2019-2030 by Country 88
8.1 Overview of European Market 88
8.2 Germany 91
8.3 UK 93
8.4 France 95
8.5 Netherlands 97
8.6 Italy 99
8.7 Russia 101
8.8 Rest of European Market 103
9 Competitive Landscape 105
9.1 Overview of Key Vendors 105
9.2 New Product Launch, Partnership, Investment, and M&A 109
9.3 Company Profiles 110
Actigraph LLC 110
Akili Interactive Labs 112
AliveCor Inc 113
Altoida Inc 114
Amgen Inc 115
Bayer AG 116
Biogen Inc 117
Cambridge Cognition Plc 118
Eli Lilly and Company 119
Evidation Health, Inc. 120
F. Hoffmann-La Roche Ltd 121
Fitbit Inc 122
GlaxoSmithKline Plc 123
Happify Health 124
Human API 125
IXICO Plc 126
Koninklijke Philips N.V. 127
Medical Care Corporation 128
Medopad Ltd 129
Mindstrong Health 130
Neurotrack Technology, Inc 131
Novartis International AG 132
Pfizer Inc. 133
Quanterix Corporation 134
Sanofi S.A. 135
The Takeda Pharmaceuticals Company Limited 136
Verily Life Sciences 137
Winterlight Labs Inc. 138
10 Investing in Europe Market: Risk Assessment and Management 139
10.1 Risk Evaluation of Europe Market 139
10.2 Critical Success Factors (CSFs) 142
Related Reports and Products 145